Related Experiment Videos
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma
S A Hahn1, D Bartsch, A Schroers
1Department of Internal Medicine, University of Bochum, Germany.
Abstract:
A candidate tumor suppressor gene, DPC4, located at 18q21.1, has recently been shown to be inactivated in half of pancreatic adenocarcinomas. The close developmental relationship of the pancreas and biliary tract prompted us to determine the role of DPC4 in the multistep carcinogenesis of biliary tract carcinoma. A search for mutations in the genomic sequence of the highly conserved COOH-terminal domain of DPC4 (exons 8-11) was performed by single-strand conformational polymorphism analysis. Five of 32 (16%) primary biliary tract carcinomas had point mutations in the DPC4 sequence. Interestingly, inactivation of DPC4 was especially common in carcinomas originating from the common bile duct (four of eight specimens analyzed), suggesting an important role for DPC4 in the development of this subtype of biliary tract tumor.
Insights
The DPC4 gene, a tumor suppressor, is frequently mutated in biliary tract cancers, particularly those from the common bile duct. This suggests DPC4 plays a key role in the development of these specific cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The DPC4 gene, a candidate tumor suppressor, is frequently inactivated in pancreatic adenocarcinomas.
- The pancreas and biliary tract share developmental origins, suggesting a potential role for DPC4 in biliary tract carcinogenesis.
Purpose of the Study:
- To investigate the role of the DPC4 gene in the multistep process of biliary tract carcinoma development.
- To identify mutations in the DPC4 gene within primary biliary tract carcinomas.
Main Methods:
- Mutation analysis of the highly conserved COOH-terminal domain of DPC4 (exons 8-11).
- Single-strand conformational polymorphism (SSCP) analysis was employed to detect mutations.
Main Results:
- Point mutations in the DPC4 gene were identified in 5 out of 32 (16%) primary biliary tract carcinomas.
- DPC4 inactivation was notably prevalent in carcinomas originating from the common bile duct (4 of 8 specimens).
Conclusions:
- The DPC4 gene is frequently altered in biliary tract carcinomas.
- Inactivation of DPC4 appears to be particularly important in the carcinogenesis of common bile duct tumors, highlighting its role as a tumor suppressor in this specific cancer subtype.